0000950170-23-049695.txt : 20230925
0000950170-23-049695.hdr.sgml : 20230925
20230925161507
ACCESSION NUMBER: 0000950170-23-049695
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230921
FILED AS OF DATE: 20230925
DATE AS OF CHANGE: 20230925
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Randhawa Simrat
CENTRAL INDEX KEY: 0001992260
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38541
FILM NUMBER: 231276023
MAIL ADDRESS:
STREET 1: 7 TIMES SQUARE
STREET 2: 43RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dianthus Therapeutics, Inc. /DE/
CENTRAL INDEX KEY: 0001690585
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 TECHNOLOGY SQUARE
STREET 2: 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-201-2700
MAIL ADDRESS:
STREET 1: 300 TECHNOLOGY SQUARE
STREET 2: 8TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Magenta Therapeutics, Inc.
DATE OF NAME CHANGE: 20161121
4
1
ownership.xml
4
X0508
4
2023-09-21
0001690585
Dianthus Therapeutics, Inc. /DE/
DNTH
0001992260
Randhawa Simrat
C/O DIANTHUS THERAPEUTICS, INC.
7 TIMES SQUARE, 43RD FLOOR
NEW YORK
NY
10036
false
true
false
false
Chief Medical Officer
false
Common Stock
2023-09-21
4
P
false
2000
13.2
A
2000
D
Common Stock
2023-09-22
4
P
false
2000
13.2
A
4000
D
/s/ Adam Veness, as attorney-in-fact for Simrat Randhawa
2023-09-25